AstraZeneca is selling European rights (excluding Spain and the UK) to the erstwhile blockbuster cholesterol drug Crestor to German pharmaceutical company Grünenthal as the British drugmaker focuses on cancer treatments.
AstraZeneca Plc will sell commercial rights for two products to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in new therapy areas.
Recently published scientific studies include research into whether Covid-19 immunity might not be possible.
A brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Scientists are baffled by how the coronavirus attacks the body – killing many patients while barely affecting others.
Mylan has come under fire from the U.S. Food and Drug Administration over inadequate good manufacturing practices at one of the company’s drug manufacturing facilities in India.
Noven Pharmaceuticals won approval from the U.S. Food and Drug Administration for the company’s transdermal schizophrenia patch.
Few nutritional supplements can protect people from developing or dying from cardiovascular disease, and some may actually be harmful, a research review suggests.
Blood pressure and stroke risk rise steadily the more alcohol people drink, and previous claims that one or two drinks a day might protect against stroke are not true, according to a genetic study.
The U.S. Food and Drug Administration will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.